Home
Home » companies

JNJ

Johnson & Johnson’s Imbruvica Will Be a Costly Treatment

Johnson & Johnson’s Imbruvica Will Be a Costly Treatment
Wall St Cheat Sheet

Johnson & Johnson Vs. Medivation In Prostate Cancer Race

Johnson & Johnson Vs. Medivation In Prostate Cancer Race
Seeking Alpha

J&J Said to Announce $4 Billion Hip-Implant Pact Nov. 19

J&J Said to Announce $4 Billion Hip-Implant Pact Nov. 19
Bloomberg

This Week in Biotech

This Week in Biotech
Motley Fool

The Anti-Kickback Statute And The Affordable Care Act: A Law Enforcement Tool Suddenly Goes Missing

The Anti-Kickback Statute And The Affordable Care Act: A Law Enforcement Tool Suddenly Goes Missing
Forbes

Alzheimer’s Clues Sought Studying Link to Down Syndrome

Alzheimer’s Clues Sought Studying Link to Down Syndrome
Bloomberg

J&J Said to Reach $4 Billion Deal to Settle Hip Lawsuits

J&J Said to Reach $4 Billion Deal to Settle Hip Lawsuits
Bloomberg

J&J's Velcade gets stiff-armed at NICE as first-line myeloma treatment

J&J's Velcade gets stiff-armed at NICE as first-line myeloma treatment
Fierce Pharma

Will Dendreon Catch Johnson & Johnson or Fall Behind Celldex?

Will Dendreon Catch Johnson & Johnson or Fall Behind Celldex?
Motley Fool

ModernGraham Valuation Of Johnson & Johnson

ModernGraham Valuation Of Johnson & Johnson
Seeking Alpha